Sales Budget:

Budgeted sales in unit

Calvimax Plus
Clarizol Drop
Econate Plus
Emixef
Esonix
Selling price per unit Total
Calvimax Plus 150
Clarizol Drop 175
Econate Plus 130
Emixef 90
Esonix 180
Percentage of sales collected in the quarter of sale 60%
Percentage of sales collected in the quarter after sale 40%
Beginning accounts receivable 665000
Production Budget:
Percentage of next year 1st quarter's sales in ending finished goods inventory 40%

Direct Materials Budget:

Direct Rawmaterials per unit
Calvimax Plus 10
Clarizol Drop 25
Econate Plus 20
Emixef 15
Esonix 25
Cost raw materials per 26
Carbon 15
Polymer 50
Percentage of next quarter's production needs in ending inventory 40%
Percentage of purchases paid in the quarter purchased 40%
Percentage of purchases paid in the quarter after purchased 60%
Beginning accounts payable 478689
Direct Labor Budget:
Direct labor -hours required per unit
Calvimax Plus 0.1
Clarizol Drop 0.04
Econate Plus 0.03
Emixef 0.03
Esonix 0.01
 Direct labor cost per hour 40

Manufacturing Overhead Budget:

Variable manufacturing overhead per direct labor-hour 50
Fixed manufacturing overhead per quarter 450000
Depreciation per quarter 200000

Selling and Administrative Expense budget:

Variable selling and administrative expense per unit 0.1
Fixed selling and administrative expense per quarter
Advertising 20000
Executive & Staff salaries 350000
Depreciation 50000
Insurance 20000
Cash Budget:
Minimum cash balance 500000
Equipment purchases 1500000
Dividends (share 200000000) 30000
Simple interest rate per quarter 10%

Beginning cash balance 600000

Things Manufacturing Private Company

Balance Sheet
31-Dec-18

Assets
Current assets
Cash 600000
Accounts receivable 665000
Raw materials inventory 1032200
Finished goods inventory 13352695
Total current assets 15649895
Plant and equipment
Land 100000000
Buildings and equipment 100000000
Accumulated depreciation 46300000
Plant and equipment net 153700000
Total assets 169349895

Liabilities and Stockholder's Equity

Current Liabilities
 Accounts payables (raw materials) 478689
Stockholder's equity
Common Stock 120000000
Retained earnings 48871206
Total stoskholder's equity 168871206
Total liabilities and stoskholder's equity 169349895
 Incepta Pharmaceuticals

Quarter
1 2 3 4 5

22000 50000 28000 30000 28000

38000 45000 25000 20500 15000
42000 30500 32000 19800 32000
25000 35000 15200 42100 26500
30000 28500 35000 35200 33300
157000 189000 135200 147600 628800

Total direct labor cost 1 2 3 4

Calvimax Plus 138000 164800 115200 116800
Clarizol Drop 86080 59200 37120 29280
Econate Plus 59040 37320 32544 29616
Emixef 42480 32496 31152 43032
Esonix 13000 12440 14032 13776
Total 338600 306256 230048 232504

Ending Materials Beginning Materials

11000 10500
15000 4500
18000 6400
25000 10000
16000 8300
85000 39700

Hour
Hour
Hour
Hour
Hour
 Tk.

Tk.
Tk.
Tk.

Tk.

Tk.
Tk.
Tk.
Tk. Others 100000

Tk.
700000 500000 300000 0

acturing Private Company

alance Sheet
31-Dec-18

Assets

nd Stockholder's Equity
Required Ending Inventoty Beginning Inventory Beginning inventory in amount

11200 7500 2066263

6000 2200 1443641
12800 5000 2623253
10600 3600 1420742
13320 8900 5798796
13352695

Year
534800
211680
158520
149160
53248
1107408
 Incepta Pharmaceuticals Ltd.
Sales budget
For the Year Ended December 31, 2019

Quarter
1 2 3
Budgeted unit sales(Calvimax Plus) 22000 50000 28000
Selling price per unit(BDT) 150 150 150
Sales 3300000 7500000 4200000

Budgeted unit sales( Clarizol ) 38000 45000 25000

Selling price per unit(BDT) 175 175 175
Sales 6650000 7875000 4375000

Budgeted unit sales(Econate ) 42000 30500 32000

Selling price per unit(BDT) 130 130 130
Sales 5460000 3965000 4160000

Budgeted unit sales( Emixef) 25000 35000 15200

Selling price per unit(BDT) 90 90 90
Sales 2250000 3150000 1368000

Budgeted unit sales(Esonix) 30000 28500 35000

Selling price per unit(BDT) 180 180 180
Sales 1 2 3
Total sales(BDT) 17660001 22490002 14103003

Schedule of Expected Cash Collections

Beginning accounts receivable 665000
First-quarter sales 10596000.6 7064000.4
Second-quarter sales 13494001.2 8996000.8
Third-quarter sales 8461801.8
Fourth-quarter sales - - -
Total cash collections 11261000.6 20558001.6 17457802.6
 Year
4
30000 130000
150 150
4500000 19500000

20500 128500
175 175
3587500 22487500

19800 124300
130 130
2574000 16159000

42100 117300
90 90
3789000 10557000

35200 128700
180 180
6336000 23166000
20786500 91869500

665000
17660001
22490002
5641201.2 14103003
12471900 12471900
18113101.2 67389906
 Incepta Pharmaceuticals LTD
Direct Materials Budget
For the Year Ended December 31, 2018
Quarter
1 2 3
Required production in units(Calvimax Plus) 30000 24000 25000
Units of raw materials needed per tiles 10 10 10
Units of raw materials needed to meet production 300000 240000 250000
Add desired units of ending raw materials inventory 96000 100000 128000
Total units of raw materials needed 396000 340000 378000
Less units of beginning raw materials inventory 10500 96000 100000
Units of raw materials to be purchased 385500 244000 278000
Cost of raw materials per kg (BDT) 26 26 26
Cost of raw materials to be purchased 10023000 6344000 7228000

Required production in units(Clarizol Drop) 15000 18000 17000

Units of raw materials needed per tiles 25 25 25
Units of raw materials needed to meet production 375000 450000 425000
Add desired units of ending raw materials inventory 180000 170000 210000
Total units of raw materials needed 555000 620000 635000
Less units of beginning raw materials inventory 4500 180000 170000
Units of raw materials to be purchased 550500 440000 465000
Cost of raw materials per kg (BDT) 26 26 26
Cost of raw materials to be purchased 14313000 11440000 12090000

Required production in units( Econate Plus) 21000 25000 32000

Units of raw materials needed per tiles 20 20 20
Units of raw materials needed to meet production 420000 500000 640000
Add desired units of ending raw materials inventory 200000 256000 144000
Total units of raw materials needed 620000 756000 784000
Less units of beginning raw materials inventory 6400 200000 256000
Units of raw materials to be purchased 613600 556000 528000
Cost of raw materials per kg (BDT) 26 26 26
Cost of raw materials to be purchased 15953600 14456000 13728000

Required production in units(Emixef) 18000 15500 13500

Units of raw materials needed per tiles 15 15 15
Units of raw materials needed to meet production 270000 232500 202500
Add desired units of ending raw materials inventory 93000 81000 118800
Total units of raw materials needed 363000 313500 321300
Less units of beginning raw materials inventory 10000 93000 81000
Units of raw materials to be purchased 353000 220500 240300
Cost of raw materials per kg (BDT) 26 26 26
Cost of raw materials to be purchased 9178000 5733000 6247800

Required production in units(Esonix) 30000 33000 24000

Units of raw materials needed per tiles 25 25 25
Units of raw materials needed to meet production 750000 825000 600000
Add desired units of ending raw materials inventory 330000 240000 250000
Total units of raw materials needed 1080000 1065000 850000
Less units of beginning raw materials inventory 8300 330000 240000
Units of raw materials to be purchased 1071700 735000 610000
Cost of raw materials per kg (BDT) 26 26 26
Cost of raw materials to be purchased 27864200 19110000 15860000

Total units of raw materials to be purchased 2974300 2195500 2121300

Total cost of raw materials to be purchased(BDT) 77331800 57083000 55153800

Total desired units of ending raw materials inventory 899000 847000 850800

Schedule of Expected Cash Disbursement for purchases of Materials

Beginning accounts payable 478689
First-quarter purchases 30932720 46399080
Second-quarter purchases 22833200 34249800
Third-quarter purchases 22061520
Fourth-quarter purchases - - -
Total cash disbursement for materials 31411409 69232280 56311320
ter
Year
4
32000 35000
10 10
320000 350000
11000 11000
331000 361000
128000 10500
203000 350500
26 26
5278000 9113000

21000 20000
25 25
525000 500000
15000 15000
540000 515000
210000 4500
330000 510500
26 26
8580000 13273000

18000 20500
20 20
360000 410000
18000 18000
378000 428000
144000 6400
234000 421600
26 26
6084000 10961600

19800 12900
15 15
297000 193500
25000 25000
322000 218500
118800 10000
203200 208500
26 26
 5283200 5421000

25000 26000
25 25
625000 650000
16000 16000
641000 666000
250000 8300
391000 657700
26 26
10166000 17100200

1361200 2148800

35391200 55868800

85000 85000

f Materials
478689
77331800
57083000
33092280 55153800
14156480 14156480
47248760 204203769
 Incepta Pharmaceuticals LTD
Production Budget
For the Year Ended December 31,2019
Quarter
1 2 3 4
Budgeted unit sales(Calvimax Plus) 22000 50000 28000 30000
Add desired units of ending finished goods inventory 20000 11200 12000 11200
Total needs 42000 61200 40000 41200
Less units of beginning finished goods inventory 7500 20000 11200 12000
Required production in units 34500 41200 28800 29200

Budgeted unit sales( Clarizol Drop) 38000 45000 25000 20500

Add desired units of ending finished goods inventory 18000 10000 8200 6000
Total needs 56000 55000 33200 26500
Less units of beginning finished goods inventory 2200 18000 10000 8200
Required production in units 53800 37000 23200 18300

Budgeted unit sales( Econate Plus) 42000 30500 32000 19800

Add desired units of ending finished goods inventory 12200 12800 7920 12800
Total needs 54200 43300 39920 32600
Less units of beginning finished goods inventory 5000 12200 12800 7920
Required production in units 49200 31100 27120 24680

Budgeted unit sales(Emixef) 25000 35000 15200 42100

Add desired units of ending finished goods inventory 14000 6080 16840 10600
Total needs 39000 41080 32040 52700
Less units of beginning finished goods inventory 3600 14000 6080 16840
Required production in units 35400 27080 25960 35860

Budgeted unit sales(Esonix) 30000 28500 35000 35200

Add desired units of ending finished goods inventory 11400 14000 14080 13320
Total needs 41400 42500 49080 48520
Less units of beginning finished goods inventory 8900 11400 14000 14080
Required production in units 32500 31100 35080 34440
Year
Produced units sold Production cost
130000
11200
141200
7500
133700 122500 275.50

128500
6000
134500
2200
132300 126300 656.20

124300
12800
137100
5000
132100 119300 524.65

117300
10600
127900
3600
124300 113700 394.65

128700
13320
142020
8900
133120 119800 651.55
Current year production cost
Beginning inventory

Cost of Goods sold

 Total

33748954.423302

82878144

62590804.7249794

44871761.9214598

78055709.9917646
302145375
13352695

315498070
 Incepta Pharmaceuticals LTD
The Direct Labor Budget
For the Year Ended December 31,2019
Quarter
1 2 3 4
Required production in units(Calvimax) 34500 41200 28800 29200
Direct labor-hours per tiles 0.1 0.1 0.1 0.1
Direct labor hours needed 3450 4120 2880 2920
Direct labor cost per hour(BDT) 40 40 40 40
Direct labor cost 138000 164800 115200 116800

Required production in units(Clarizol) 53800 37000 23200 18300

Direct labor-hours per tiles 0.04 0.04 0.04 0.04
Direct labor hours needed 2152 1480 928 732
Direct labor cost per hour(BDT) 40 40 40 40
Direct labor cost 86080 59200 37120 29280

Required production in units( Econate) 49200 31100 27120 24680

Direct labor-hours per tiles 0.03 0.03 0.03 0.03
Direct labor hours needed 1476 933 813.6 740.4
Direct labor cost per hour(BDT) 40 40 40 40
Direct labor cost 59040 37320 32544 29616

Required production in units(Emixef) 35400 27080 25960 35860

Direct labor-hours per tiles 0.03 0.03 0.03 0.03
Direct labor hours needed 1062 812.4 778.8 1075.8
Direct labor cost per hour(BDT) 40 40 40 40
Direct labor cost 42480 32496 31152 43032

Required production in units(Econate) 32500 31100 35080 34440

Direct labor-hours per tiles 0.01 0.01 0.01 0.01
Direct labor hours needed 325 311 350.8 344.4
Direct labor cost per hour(BDT) 40 40 40 40
Direct labor cost 13000 12440 14032 13776

Total direct labor hours needed 8465 7656.4 5751.2 5812.6

Total direct labor cost (BDT) 338600 306256 230048 232504
Year
133700
0.1
13370
40
534800

132300
0.04
5292
40
211680

132100
0.03
3963
40
158520

124300
0.03
3729
40
149160

133120
0.01
1331.2
40
53248

27685.2
1107408
 Incepta Pharmaceuticals LTD
The Manufacturing Overhead Budget
For the Year Ended December 31,2019
Quarter
Year
1 2 3 4
Budgeted direct labor-hours 8465 7656.4 5751.2 5812.6 27685.2
Variable manufacturing overhead rate(BDT) 50 50 50 50 50
Variable manufacturing overhead(BDT) 423250 382820 287560 290630 1384260
Fixed manufacturing overhead(BDT) 450000 450000 450000 450000 1800000
Total manufacturing overhead(BDT) 873250 832820 737560 740630 3184260
Less depreciation(BDT) 200000 200000 200000 200000 800000
Cash disbursement for manufacturing
overhead 673250 632820 537560 540630 2384260

Total manufacturing overhead 3184260

Budgeted direct labor hours 27685.2
Predetermined overhead rate for the year 115.0167
 Incepta Pharmaceuticals LTD
Ending Finished Goods Inventory Budget
(Absorption Costing Basis)
For the year Ended December 31, 2019

Item Quantity Cost Total(BDT)

Production Cost Per Unit:(Calvimax)
Direct Materials 10 units 26 per unit 260
Direct Labor 0.1 hours 40 per hour 4
Manufacturing Overhead 0.1 hours 115.02 per hour 11.50
Unit Product Cost 275.50

Budgeted Finished Goods Inventory:

Ending finished goods inventory in unit 11200
Unit Product cost (see above) 275.50
Ending finished goods inventory in BDT 3085619

Production Cost Per Unit:(Clarizol)

Direct Materials 25 units 26 per unit 650
Direct Labor 0.04 hours 40 per hour 1.6
Manufacturing Overhead 0.04 hours 115.02 per hour 4.60
Unit Product Cost 656.20

Budgeted Finished Goods Inventory:

Ending finished goods inventory in unit 6000
Unit Product cost (see above) 656.20
Ending finished goods inventory in BDT 3937204

Production Cost Per Unit:( Econate)

Direct Materials 20 units 26 per unit 520
Direct Labor 0.03 hours 40 per hour 1.2
Manufacturing Overhead 0.03 hours 115.02 per hour 3.45
Unit Product Cost 524.65

Budgeted Finished Goods Inventory:

Ending finished goods inventory in unit 12800
Unit Product cost (see above) 524.65
Ending finished goods inventory in BDT 6715526

Production Cost Per Unit:(Emixef)

Direct Materials 15 units 26 per unit 390
Direct Labor 0.03 hours 40 per hour 1.2
Manufacturing Overhead 0.03 hours 115.02 per hour 3.45
Unit Product Cost 394.65

Budgeted Finished Goods Inventory:

Ending finished goods inventory in unit 10600
Unit Product cost (see above) 394.65
Ending finished goods inventory in BDT 4183295

Production Cost Per Unit:(Econate)

Direct Materials 25 units 26 per unit 650
Direct Labor 0.01 hours 40 per hour 0.4
Manufacturing Overhead 0.01 hours 115.02 per hour 1.15
Unit Product Cost 651.55

Budgeted Finished Goods Inventory:

Ending finished goods inventory in unit 13320
Unit Product cost (see above) 651.55
Ending finished goods inventory in BDT 8678648

Total ending finished goods inventory in BDT 26600293

 Incepta Pharmaceuticals LTD
Selling and Administrative Expense Budget
For the year Ended December 31, 2019

Quarter
1 2 3
Budgeted units sales 157000 189000 135200
Variable selling and administrative expense per unit(BDT) 0.1 0.1 0.1
Variable selling and administrative expense 15700 18900 13520
Fixed selling and administrative expenses(BDT)
Advertising 20000 20000 20000
Executive salaries 350000 350000 350000
Insurance 20000 20000 20000
Depreciation 50000 50000 50000
Others 100000 100000 100000
Total Fixed selling and administrative expenses 540000 540000 540000
Total selling and administrative expenses(BDT) 555700 558900 553520
Less Depreciation 50000 50000 50000
Cash disbursement for selling and administrative expenses 505700 508900 503520
rter
Year
4
147600 628800
0.1 0.1
14760 62880

20000 80000
350000 1400000
20000 80000
50000 200000
100000 400000
540000 2160000
554760 2222880
50000 200000
504760 2022880
 Incepta Pharmaceuticals LTD
Cash Budget
For the year Ended December 31, 2019

Quarter
1 2 3
Biginning cash balance(BDT) 600000 502583 501455
Add cash receipts(BDT)
Collections from customers 11261000.6 20558001.6 17457802.6
Total cash available 11861000.6 21060584.6 17959257.6
Less cash disbursments(BDT)
Direct materials 31411409 69232280 56311320
Direct labor 338600 306256 230048
Manufacturing overhead 673250 632820 537560
Selling and administrative 505700 508900 503520
Equipment purchases 700000 500000 300000
Dividends 30000 30000 30000
Total cash disbursement 33658959 71210256 57912448
Excess (dificiency) of cash available over
disbursement -21797958.4 -50149671.4 -39953190.4
Financing(BDT)
Borrowings (at the biginnings of quarters) 22300541.4 50651126.4
Repayments (at the end of year)
Interest
Total financing 22300541.4 50651126.4 0
Ending cash balance(BDT) 502583 501455 -39953190.4
19

4 Year
-39953190.4 600000

18113101.2 67389906
-21840089.2 67989906

47248760 204203769
232504 1107408
540630 2384260
504760 2022880
0 1500000
30000 120000
48556654 211338317

-70396743.2 -143348411

72951667.8
-72951667.8 -72951667.8
-6028889 -6028889
-78980556 -6028888.62
-149377299.62 -149377299.62
 Incepta Pharmaceuticals LTD
Budgeted Income Statement
For the year Ended December 31, 2019

Amount(BDT)
Sales 91869500
Cost of goods sold 315498070
Gross margin -223628570
Selling and administrative expenses 2222880
Net operating income -225851450
Interest expense -6028889
Net income -231880339
 Incepta Pharmaceuticals LTD
Budgeted Balance Sheet
31-Dec-19

Amount (BDT) Amount (BDT)

Assets
Current assets
Cash -149377300
Accounts receivable 8314600
Raw materials inventory 2210000
Finished goods inventory 26600293
Total current assets -112252407
Plant and equipment
Land 100000000
Buildings and equipment 101500000
Accumulated depreciation 47300000
Plant and equipment net 154200000
Total assets 41947593

Liabilities and Stockholder's Equity

Current Liabilities
Accounts payables (raw materials) 21234720
Stockholder's equity
Common Stock no par 120000000
Retained earnings -183129133
Total stockholder's equity -63129133
Total liabilities and stoskholder's equity -41894413